Ameritas Investment Company’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Ameritas Investment Company’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$962K	Buy	7,649 +3,019	+65%	+$389K	0.04%	282
2021 Q2	$996K	Buy	4,630 +1,498	+48%	+$197K	0.05%	284
2021 Q1	$425K	Sell	3,132 -1,742	-36%	-$261K	0.04%	384
2020 Q4	$686K	Buy	4,874 +970	+25%	+$124K	0.13%	168
2020 Q3	$437K	Hold	3,904	–	–	0.14%	183
2020 Q2	$437K	Sell	3,904 -401	-9%	-$39.5K	0.13%	187
2020 Q1	$330K	Buy	4,305 +852	+25%	+$75.4K	0.05%	252
2019 Q4	$328K	Sell	3,453 -971	-22%	-$84K	0.07%	243
2019 Q3	$344K	Buy	+4,424	New	+$368K	0.07%	244
2019 Q2	–	Sell	-4,144	Closed	-$375K	–	891
2019 Q1	$375K	Sell	4,144 -3,785	-48%	-$322K	0.07%	215
2018 Q4	$569K	Buy	+7,929	New	+$639K	0.12%	149

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Ameritas Investment Company's XBI Position: Q3 2021 in Review

Ameritas Investment Company increased its State Street SPDR S&P Biotech ETF (XBI) stake by 65% in Q3 2021, buying an estimated $389K and bringing the position to 7,649 shares worth $962K. The position accounts for 0.04% of the portfolio, ranked #282.

Ameritas Investment Company first reported a position in XBI in Q4 2018 and has held it in 11 quarters since. The position peaked at $996K in Q2 2021. 635 funds tracked by Wall St. Rank hold XBI as of Q3 2021.

Ameritas Investment Company held 7,649 shares of State Street SPDR S&P Biotech ETF worth $962K as of Q3 2021.
Ameritas Investment Company bought 3,019 State Street SPDR S&P Biotech ETF shares in Q3 2021, an estimated $389K.
State Street SPDR S&P Biotech ETF made up 0.04% of Ameritas Investment Company's portfolio in Q3 2021, its #282 holding.
Ameritas Investment Company first reported a position in State Street SPDR S&P Biotech ETF in Q4 2018 and has held it in 11 quarters since.
Ameritas Investment Company's State Street SPDR S&P Biotech ETF position peaked at $996K in Q2 2021.
635 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2021.

Based on Ameritas Investment Company's 13F filing for Q3 2021, filed 12 Nov 2021.